A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests (TACT)
Malaria
About this trial
This is an interventional health services research trial for Malaria focused on measuring malaria, rdt, fever, treatment
Eligibility Criteria
Health Facility Inclusion criteria:
- Located in lowland Muheza, adjoining wards of Handeni, or any area of Moshi Rural Districts
- Health facilities that are registered with the District Health Authority
- Receives Government supplies of ALu and qualifies for RDT supply
- Agrees to exclusive use of RDT for routine diagnosis of first consultations for possible malaria
- Accessible by 4-wd vehicle throughout the year.
- Availability of data on proportion of consultations diagnosed with malaria in 2008 (or earliest available year)
Health Facility Exclusion:
- Presence of other research in the immediate area where study procedures could bias outcomes in either study.
- Fewer than 500 cases per year were reported in 2005 or 2006.
Patient Inclusion:
- All patients with non-severe illness in first consultations.
- Patient Exclusion
- Patients who have been referred to the next level of care
- Patient refuses consent to exit survey
- Follow-up consultations
Sites / Locations
- Joint Malaria Programme
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Control
HW
HWC
Prescribing staff in control facilities will receive the standard package of RDT training that is being provided by NMCP in Tanzania
Prescribing staff in the intervention facilities will receive the same package of nationally-approved training in RDT use as will be provided to prescribers in control facilities. Following this, prescribers in the intervention facilities will be invited to participate in 3 small group training modules delivered in an interactive style lasting approximately 11/2 hours, with one session repeated between the 6th and 7th month of the trial.
The health worker-community arm will receive the same intervention as the health workers arm but with the addition of an intervention aimed at patients. This will consist of community sensitisation, clinic posters and providing a leaflet to each RDT-tested patient or caretaker giving details of the test and the corresponding treatment provided.